Member Info for PeterS23

“Sensational news in a month or so”. Cath Friel.

The financial results were for the year ended 31st December 2019, and as such I think most people who’ve invested here since the beginning of this year are neither vexed or pleased by the results announced. Does anyone posting here, however, have any information they can share regarding current sales projections etc that MW have commented upon? Thanks in advance

The main thrust of the article is that SNG have a lot to do to get the product to the market, and are no Gilead in this respect. Small fish in a big pond etc. Whilst true, Motley Fool are telling us all something that we shareholders should already know and what the BOD of SNG will definitely already know. The Chairman and Finance Director have CV’s and huge experience in such corporate matters. Hence a plan will already be in place to ensure that no brick wall is hit in SNG’s efforts to get this product to market. There are a few routes the Company can take, but there will be a road map already in place.

Deepjoy, I have a recollection that CF, sometime recently, said that OO had approached Acacia and offered to buy their shareholding at “market rates” but they refused. He commented it was “very strange”.

This is a Company that clearly needed cash in order to survive and thrive. When you think about it, it should be no surprise that this dilution at a reduced share price has happened BEFORE the METS and any announcement of EU funding. The BOD will have been negotiating the fund raising for weeks, or months. The people funding the £2 million will have negotiated very hard for their cash injection given the current economic climate. Thus the ballpark (if not exact price) that the BOD could get (inclusive of any METS and EU positives) will have been settled at 12.75p for the shares issued. Now, if they had first announced the METS and EU positives, before the dilution, then the share price would have very likely risen (to 20p plus? on the back of those two pieces of news). If they then announced the share placing (at the previously negotiated and agreed price of 12.75p) then existing shareholders would have been even more miffed than they are now. Hence the sequence they’ve done it, is the lesser of two evils, and given good news should now shortly be arriving, then the share price could achieve a nice bounce from here. All IMO only.

Agree with Gizzard’s sentiments. I assume most investors here are invested because they strongly believe the share price will multibag over the coming year or two (ie increase 200, 300, 400% or more). Therefore a 20% hit on the price now is a relatively small price to pay for a major cash injection which will assist greatly in helping the Company achieve more rapidly its short/medium term growth and profitability targets. All shareholders will then benefit from a higher share price, achieved in a quicker timeframe, than would otherwise be the case without the fundraising. IMO

Re value of Imutex;

I agree $300 to $500 valuation has been mentioned by CF previously but remember ORPH only own 49% so that has to be taken into account .

However not sure if the stage 1 Malaria drug is within the valuation. Might be extra.

Moniman, the “true” value you mention is subjective in that all investors on this board believe ORPH will increase its share price, but others, including those who sell these shares every day, do not believe the share price will increase. Alternatively some sellers will be compelled to sell, for various reasons, even if they believe the share price will increase.

Hi Poorman

Agreed. I too don’t subscribe to conspiratorial theories. It’s just markets working, warts and all.

Poorman, the “orchestrated” comment will refer to the Link/Acacia shareholding that Acacia had/still have in ORPH. Link acquired ORPH shares following the winding down of Neil Woodfords investment fund fiasco. Link sold the shareholding in ORPH (and a dozen or so other Company shareholding’s , including Synairgen) to Acacia. They were sold cheaply, and hence Acacia have been selling the shares steadily (to realise the profit) and this is keeping the share price steady, as any rise is swiftly curtailed through the selling.

They put a £0.33p “fair” value per share

Simplywall.st have published a report on their website valuing OO’s share price at 62% below value

Ringthebell . Excellent post at 8:15 today. Says it all why this is a share to hold on to and top up at the current price. Bargain.

Nice 1 UpUp. Keep up the good work.

Big thanks to :

A) Sabah Meddings of the Sunday Times for tipping this share on 29/03 when share price was 50p. Thanks to her I found this share and invested (at 52p)

B) The regular posters on this board (Rich, Ghia et al) who kept their nerve and confidence and posted some really useful information, which meant waverers like me (when price dropped to low 30’s) held on, kept the faith, and have now been rewarded.

PS not sold a share and keeping hold to see where this ride take me.

nst1 - what does a big spread on the price usually mean in terms of market sentiment?

Ironman , the way I read it Shareseeker expressed an opinion and wasn’t ramping. I can’t see anywhere in his post where he stated that he’d “researched fully every single Company on AIM” nor has he stated ORPH to be a “certainty” as you imply. In fact he stated it was only “in his experience”.

Thanks Zebbo for your post. Much appreciated.

39p based on no news next week.

If positive news, in coming weeks/months ; £3.60 . Based on Simmo222’s Friday post in which he mentioned brokers upper assessment of £3.60. Why wouldn’t it scale these heights given the huge gravity of the global problem that could be largely mitigated? AIMO

https://www.thetimes.co.uk/article/open-orphan-boss-cathal-friel-offers-his-prescription-for-success-5vd5ktg2d

From a year ago. Probably posted previously by somebody on here but worth a read. We’re in safe hands me thinks and the valuation has increased beyond recognition, post COVID.